Streptococcal toxins: Role in pathogenesis and disease

Cellular Microbiology

Volumn 17, Issue 12, 2015, Pages 1721-1741

  Barnett, Timothy C ^a   Cole, Jason N ^a,b   Rivera Hernandez, Tania ^a   Henningham, Anna ^a,b   Paton, James C ^c   Nizet, Victor ^b   Walker, Mark J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOLYSIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE NUCLEOSIDASE; PNEUMOLYSIN; PROTEINASE; STAPHYLOCOCCUS TOXIN; STREPTOLYSIN O; STREPTOLYSIN S; SUILYSIN; SUPERANTIGEN; UNCLASSIFIED DRUG; BACTERIAL TOXIN; VIRULENCE FACTOR;

BACTERIAL VIRULENCE; CARBOXY TERMINAL SEQUENCE; CELL STIMULATION; CELLULAR IMMUNITY; GENOME; HUMAN; HUMAN CELL; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS ANGINOSUS; STREPTOCOCCUS CONSTELLATUS; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INIAE; STREPTOCOCCUS INTERMEDIUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; STREPTOCOCCUS SUIS; UNFOLDED PROTEIN RESPONSE; HOST PATHOGEN INTERACTION; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; STREPTOCOCCUS INFECTION;

BACTERIAL TOXINS; HOST-PATHOGEN INTERACTIONS; HUMANS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; VIRULENCE FACTORS;

EID: 84948076325     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/cmi.12531     Document Type: Review

References (264)

1. Abe, J., Kotzin, B.L., Jujo, K., Melish, M.E., Glode, M.P., Kohsaka, T., and Leung, D.Y.M. (1992) Selective expansion of T cells expressing T-cell receptor variable regions Vβ2 and Vβ8 in Kawasaki disease. Proc Natl Acad Sci U S A 89: 4066-4070.
2. Alam, F.M., Bateman, C., Turner, C.E., Wiles, S., and Sriskandan, S. (2013) Non-invasive monitoring of Streptococcus pyogenes vaccine efficacy using biophotonic imaging. PLoS One 8: e82123.
3. Alcantara, R.B., Preheim, L.C., and Gentry-Nielsen, M.J. (2001) Pneumolysin-induced complement depletion during experimental pneumococcal bacteremia. Infect Immun 69: 3569-3575.
4. Alexander, J.E., Lock, R.A., Peeters, C.C.A.M., Poolman, J.T., Andrew, P.W., Mitchell, T.J., et al. (1994) Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae. Infect Immun 62: 5683-5688.
5. Alhamdi, Y., Neill, D.R., Abrams, S.T., Malak, H.A., Yahya, R., Barrett-Jolley, R., et al. (2015) Circulating pneumolysin is a potent inducer of cardiac injury during pneumococcal infection. PLoS Pathog 11: e1004836.
6. Allen, A.G., Bolitho, S., Lindsay, H., Khan, S., Bryant, C., Norton, P., et al. (2001) Generation and characterization of a defined mutant of Streptococcus suis lacking suilysin. Infect Immun 69: 2732-2735.
7. Anderson, R., Steel, H.C., Cockeran, R., von Gottberg, A., de Gouveia, L., Klugman, K.P., et al. (2007) Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro. J Antimicrob Chemother 60: 1155-1158.
8. Arad, G., Levy, R., Nasie, I., Hillman, D., Rotfogel, Z., Barash, U., et al. (2011) Binding of superantigen toxins into the CD28 homodimer interface is essential for induction of cytokine genes that mediate lethal shock. PLoS Biol 9: e1001149.
9. Asam, D., Mauerer, S., and Spellerberg, B. (2015) Streptolysin S of Streptococcus anginosus exhibits broad-range hemolytic activity. Med Microbiol Immun 204: 227-237.
10. Ato, M., Ikebe, T., Kawabata, H., Takemori, T., and Watanabe, H. (2008) Incompetence of neutrophils to invasive group A Streptococcus is attributed to induction of plural virulence factors by dysfunction of a regulator. PLoS One 3: e3455.
11. Ayers, S.H., and Rupp, P. (1922) Differentiation of hemolytic streptococci from human and bovine sources by the hydrolysis of sodium hippurate. J Infect Dis 30: 388-399.
12. Aziz, R.K., Pabst, M.J., Jeng, A., Kansal, R., Low, D.E., Nizet, V., and Kotb, M. (2004) Invasive M1T1 group A Streptococcus undergoes a phase-shift in vivo to prevent proteolytic degradation of multiple virulence factors by SpeB. Mol Microbiol 51: 123-134.
13. Barnett, T.C., Liebl, D., Seymour, L.M., Gillen, C.M., Lim, J.Y., Larock, C.N., et al. (2013) The globally disseminated M1T1 clone of group A Streptococcus evades autophagy for intracellular replication. Cell Host Microbe 14: 675-682.
14. Baruch, M., Hertzog, B.B., Ravins, M., Anand, A., Cheng, C.Y., Biswas, D., et al. (2014) Induction of endoplasmic reticulum stress and unfolded protein response constitutes a pathogenic strategy of group A Streptococcus. Front Cell Infect Microbiol 4: 105.
15. Bastiat-Sempe, B., Love, J.F., Lomayesva, N., and Wessels, M.R. (2014) Streptolysin O and NAD-glycohydrolase prevent phagolysosome acidification and promote group a Streptococcus survival in macrophages. mBio 5: e01690-01614.
16. Bek-Thomsen, M., Poulsen, K., and Kilian, M. (2012) Occurrence and evolution of the paralogous zinc metalloproteases IgA1 protease, ZmpB, ZmpC, and ZmpD in Streptococcus pneumoniae and related commensal species. mBio 3: e00303-e00312.
17. Bender, M.H., and Weiser, J.N. (2006) The atypical amino-terminal LPNTG-containing domain of the pneumococcal human IgA1-specific protease is required for proper enzyme localization and function. Mol Microbiol 61: 526-543.
18. Bensi, G., Mora, M., Tuscano, G., Biagini, M., Chiarot, E., Bombaci, M., et al. (2012) Multi high-throughput approach for highly selective identification of vaccine candidates: the group A Streptococcus case. Mol Cell Proteomics 11: M111.015693.
19. Benton, K.A., Everson, M.P., and Briles, D.E. (1995) A pneumolysin-negative mutant of Streptococcus pneumoniae causes chronic bacteremia rather than acute sepsis in mice. Infect Immun 63: 448-455.
20. Beres, S.B., Sylva, G.L., Barbian, K.D., Lei, B., Hoff, J.S., Mammarella, N.D., et al. (2002) Genome sequence of a serotype M3 strain of group A Streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence. Proc Natl Acad Sci U S A 99: 10078-10083.
21. Berge, A., and Bjorck, L. (1995) Streptococcal cysteine proteinase releases biologically active fragments of streptococcal surface proteins. J Biol Chem 270: 9862-9867.
22. Bernheimer, A.W. (1966) Disruption of wall-less bacteria by streptococcal and staphylococcal toxins. J Bacteriol 91: 1677-1680.
23. Bernheimer, A.W. (1967) Physical behavior of streptolysin S. J Bacteriol 93: 2024-2025.
24. Berry, A.M., Lock, R.A., Hansman, D., and Paton, J.C. (1989a) Contribution of autolysin to virulence of Streptococcus pneumoniae. Infect Immun 57: 2324-2330.
25. Berry, A.M., Yother, J., Briles, D.E., Hansman, D., and Paton, J.C. (1989b) Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae. Infect Immun 57: 2037-2042.
26. Berry, A.M., Paton, J.C., and Hansman, D. (1992) Effect of insertional inactivation of the genes encoding pneumolysin and autolysin on the virulence of Streptococcus pneumoniae type 3. Microb Pathog 12: 87-93.
27. Betschel, S.D., Borgia, S.M., Barg, N.L., Low, D.E., and De Azavedo, J.C. (1998) Reduced virulence of group A streptococcal Tn916 mutants that do not produce streptolysin S. Infect Immun 66: 1671-1679.
28. Bischof, L.J., Kao, C.Y., Los, F.C., Gonzalez, M.R., Shen, Z., Briggs, S.P., et al. (2008) Activation of the unfolded protein response is required for defenses against bacterial pore-forming toxin in vivo. PLoS Pathog 4: e1000176.
29. Bjorck, L., Akesson, P., Bohus, M., Trojnar, J., Abrahamson, M., Olafsson, I., and Grubb, A. (1989) Bacterial growth blocked by a synthetic peptide based on the structure of a human proteinase inhibitor. Nature 337: 385-386.
30. Blue, C.E., Paterson, G.K., Kerr, A.R., Berge, M., Claverys, J.P., and Mitchell, T.J. (2003) ZmpB, a novel virulence factor of Streptococcus pneumoniae that induces tumor necrosis factor alpha production in the respiratory tract. Infect Immun 71: 4925-4935.
31. Bohach, G.A., Hauser, A.R., and Schlievert, P.M. (1988) Cloning of the gene, speB, for streptococcal pyrogenic exotoxin type B in Escherichia coli. Infect Immun 56: 1665-1667.
32. Bonifait, L., and Grenier, D. (2011a) The SspA subtilisin-like protease of Streptococcus suis triggers a pro-inflammatory response in macrophages through a non-proteolytic mechanism. BMC Microbiol 11: 47.
33. Bonifait, L., de la Cruz Dominguez-Punaro, M., Vaillancourt, K., Bart, C., Slater, J., Frenette, M., et al. (2010) The cell envelope subtilisin-like proteinase is a virulence determinant for Streptococcus suis. BMC Microbiol 10: 42.
34. Bonifait, L., Vaillancourt, K., Gottschalk, M., Frenette, M., and Grenier, D. (2011b) Purification and characterization of the subtilisin-like protease of Streptococcus suis that contributes to its virulence. Vet Microbiol 148: 333-340.
35. Bouyain, S., and Geisbrecht, B.V. (2012) Host glycan recognition by a pore forming toxin. Structure 20: 197-198.
36. Bricker, A.L., Cywes, C., Ashbaugh, C.D., and Wessels, M.R. (2002) NAD+-glycohydrolase acts as an intracellular toxin to enhance the extracellular survival of group A streptococci. Mol Microbiol 44: 257-269.
37. Bricker, A.L., Carey, V.J., and Wessels, M.R. (2005) Role of NADase in virulence in experimental invasive group A streptococcal infection. Infect Immun 73: 6562-6566.
38. Brosnahan, A.J., and Schlievert, P.M. (2011) Gram-positive bacterial superantigen outside-in signaling causes toxic shock syndrome. FEBS J 278: 4649-4667.
39. Brosnahan, A.J., Mantz, M.J., Squier, C.A., Peterson, M.L., and Schlievert, P.M. (2009) Cytolysins augment superantigen penetration of stratified mucosa. J Immunol 182: 2364-2373.
40. Broudy, T.B., and Fischetti, V.A. (2003) In vivo lysogenic conversion of Tox(-) Streptococcus pyogenes to Tox(+) with lysogenic streptococci or free phage. Infect Immun 71: 3782-3786.
41. Carr, A., Sledjeski, D.D., Podbielski, A., Boyle, M.D., and Kreikemeyer, B. (2001) Similarities between complement-mediated and streptolysin S-mediated hemolysis. J Biol Chem 276: 41790-41796.
42. Carroll, R.K., and Musser, J.M. (2011) From transcription to activation: how group A streptococcus, the flesh-eating pathogen, regulates SpeB cysteine protease production. Mol Microbiol 81: 588-601.
43. Cassidy, S.K., and O'Riordan, M.X. (2013) More than a pore: the cellular response to cholesterol-dependent cytolysins. Toxins 5: 618-636.
44. Chabot-Roy, G., Willson, P., Segura, M., Lacouture, S., and Gottschalk, M. (2006) Phagocytosis and killing of Streptococcus suis by porcine neutrophils. Microb Pathog 41: 21-32.
45. Chandrasekaran, S., Ghosh, J., Port, G.C., Koh, E.I., and Caparon, M.G. (2013) Analysis of polymorphic residues reveals distinct enzymatic and cytotoxic activities of the Streptococcus pyogenes NAD+ glycohydrolase. J Biol Chem 288: 20064-20075.
46. Charland, N., Nizet, V., Rubens, C.E., Kim, K.S., Lacouture, S., and Gottschalk, M. (2000) Streptococcus suis serotype 2 interactions with human brain microvascular endothelial cells. Infect Immun 68: 637-643.
47. Chatellier, S., Ihendyane, N., Kansal, R.G., Khambaty, F., Basma, H., Norrby-Teglund, A., et al. (2000) Genetic relatedness and superantigen expression in group A Streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases. Infect Immun 68: 3523-3534.
48. Chella Krishnan, K., Mukundan, S., Landero Figueroa, J.A., Caruso, J.A., and Kotb, M. (2014) Metal-mediated modulation of streptococcal cysteine protease activity and its biological implications. Infect Immun 82: 2992-3001.
49. Chen, C.C., and Cleary, P.P. (1990) Complete nucleotide sequence of the streptococcal C5a peptidase gene of Streptococcus pyogenes. J Biol Chem 265: 3161-3167.
50. Chen, Y., Hayashida, A., Bennett, A.E., Hollingshead, S.K., and Park, P.W. (2007) Streptococcus pneumoniae sheds syndecan-1 ectodomains through ZmpC, a metalloproteinase virulence factor. J Biol Chem 282: 159-167.
51. Cheng, Q., Debol, S., Lam, H., Eby, R., Edwards, L., Matsuka, Y., et al. (2002a) Immunization with C5a peptidase or peptidase-type III polysaccharide conjugate vaccines enhances clearance of group B streptococci from lungs of infected mice. Infect Immun 70: 6409-6415.
52. Cheng, Q., Stafslien, D., Purushothaman, S.S., and Cleary, P. (2002b) The group B streptococcal C5a peptidase is both a specific protease and an invasin. Infect Immun 70: 2408-2413.
53. Chiang-Ni, C., Wang, C.H., Tsai, P.J., Chuang, W.J., Lin, Y.S., Lin, M.T., et al. (2006) Streptococcal pyrogenic exotoxin B causes mitochondria damage to polymorphonuclear cells preventing phagocytosis of group A Streptococcus. Med Microbiol Immun 195: 55-63.
54. Chiappini, N., Seubert, A., Telford, J.L., Grandi, G., Serruto, D., Margarit, I., and Janulczyk, R. (2012) Streptococcus pyogenes SpyCEP influences host-pathogen interactions during infection in a murine air pouch model. PLoS One 7: e40411.
55. Chiarot, E., Faralla, C., Chiappini, N., Tuscano, G., Falugi, F., Gambellini, G., et al. (2013) Targeted amino acid substitutions impair streptolysin O toxicity and group A Streptococcus virulence. mBio 4: e00387-00312.
56. Chiavolini, D., Memmi, G., Maggi, T., Iannelli, F., Pozzi, G., and Oggioni, M.R. (2003) The three extra-cellular zinc metalloproteinases of Streptococcus pneumoniae have a different impact on virulence in mice. BMC Microbiol 3: 14.
57. Christie, R., Atkins, N.E., and Munch-Petersen, E. (1944) A note on a lytic phenomenon shown by group B streptococci. Aust J Exp Biol 22: 197-200.
58. Chuzeville, S., Puymege, A., Madec, J.Y., Haenni, M., and Payot, S. (2012) Characterization of a new CAMP factor carried by an integrative and conjugative element in Streptococcus agalactiae and spreading in streptococci. PLoS One 7: e48918.
59. Cleary, P.P., Handley, J., Suvorov, A.N., Podbielski, A., and Ferrieri, P. (1992) Similarity between the group B and A streptococcal C5a peptidase genes. Infect Immun 60: 4239-4244.
60. Cole, J.N., McArthur, J.D., McKay, F.C., Sanderson-Smith, M.L., Cork, A.J., Ranson, M., et al. (2006) Trigger for group A streptococcal M1T1 invasive disease. FASEB J 20: 1745-1747.
61. Cole, J.N., Barnett, T.C., Nizet, V., and Walker, M.J. (2011) Molecular insight into invasive group A streptococcal disease. Nature Rev Microbiol 9: 724-736.
62. Collin, M., and Olsen, A. (2003) Extracellular enzymes with immunomodulating activities: variations on a theme in Streptococcus pyogenes. Infect Immun 71: 2983-2992.
63. Commons, R.J., Smeesters, P.R., Proft, T., Fraser, J.D., Robins-Browne, R., and Curtis, N. (2014) Streptococcal superantigens: categorization and clinical associations. Trends Mol Med 20: 48-62.
64. Cortes, G., and Wessels, M.R. (2009) Inhibition of dendritic cell maturation by group A Streptococcus. J Infect Dis 200: 1152-1161.
65. Cotter, P.D., Hill, C., and Ross, R.P. (2005) Bacteriocins: developing innate immunity for food. Nature Rev Microbiol 3: 777-788.
66. Coye, L.H., and Collins, C.M. (2004) Identification of SpyA, a novel ADP-ribosyltransferase of Streptococcus pyogenes. Mol Microbiol 54: 89-98.
67. Curtis, N., Zheng, R., Lamb, J.R., and Levin, M. (1995) Evidence for a superantigen mediated process in Kawasaki disease. Arch Dis Child 72: 308-311.
68. Cywes Bentley, C., Hakansson, A., Christianson, J., and Wessels, M.R. (2005) Extracellular group A Streptococcus induces keratinocyte apoptosis by dysregulating calcium signalling. Cell Microbiol 7: 945-955.
69. Dal, M.-C., and Monteil, H. (1983) Hemolysin produced by group B Streptococcus agalactiae. FEMS Microbiol Lett 16: 89-94.
70. Davies, M.R., Holden, M.T., Coupland, P., Chen, J.H., Venturini, C., Barnett, T.C., et al. (2015) Emergence of scarlet fever Streptococcus pyogenes emm12 clones in Hong Kong is associated with toxin acquisition and multidrug resistance. Nat Genet 47: 84-87.
71. Davis, M.M., and Bjorkman, P.J. (1988) T-cell antigen receptor genes and T-cell recognition. Nature 334: 395-402.
72. Doran, K.S., Liu, G.Y., and Nizet, V. (2003) Group B streptococcal beta-hemolysin/cytolysin activates neutrophil signaling pathways in brain endothelium and contributes to development of meningitis. J Clin Invest 112: 736-744.
73. Dramsi, S., and Cossart, P. (2002) Listeriolysin O: a genuine cytolysin optimized for an intracellular parasite. J Cell Biol 156: 943-946.
74. Eckes, B., Colucci-Guyon, E., Smola, H., Nodder, S., Babinet, C., Krieg, T., and Martin, P. (2000) Impaired wound healing in embryonic and adult mice lacking vimentin. J Cell Sci 113(Pt 13): 2455-2462.
75. Edwards, R.J., Taylor, G.W., Ferguson, M., Murray, S., Rendell, N., Wrigley, A., et al. (2005) Specific C-terminal cleavage and inactivation of interleukin-8 by invasive disease isolates of Streptococcus pyogenes. J Infect Dis 192: 783-790.
76. El-Huneidi, W., Mui, R., Zhang, T.H., and Palmer, M. (2007) Streptococcus agalactiae CAMP factor/protein B does not bind to human IgG. Med Microbiol Immun 196: 73-77.
77. Eriksson, B.K., Andersson, J., Holm, S.E., and Norgren, M. (1999) Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome. J Infect Dis 180: 410-418.
78. Farley, M.M. (2001) Group B streptococcal disease in nonpregnant adults. Clin Infect Dis 33: 556-561.
79. Farrand, S., Hotze, E., Friese, P., Hollingshead, S.K., Smith, D.F., Cummings, R.D., et al. (2008) Characterization of a streptococcal cholesterol-dependent cytolysin with a lewis y and b specific lectin domain. Biochemistry 47: 7097-7107.
80. Fasching, C.E., Grossman, T., Corthesy, B., Plaut, A.G., Weiser, J.N., and Janoff, E.N. (2007) Impact of the molecular form of immunoglobulin A on functional activity in defense against Streptococcus pneumoniae. Infect Immun 75: 1801-1810.
81. Fast, D.J., Schlievert, P.M., and Nelson, R.D. (1989) Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production. Infect Immun 57: 291-294.
82. Fittipaldi, N., Segura, M., Grenier, D., and Gottschalk, M. (2012) Virulence factors involved in the pathogenesis of the infection caused by the swine pathogen and zoonotic agent Streptococcus suis. Future Microbiol 7: 259-279.
83. Flanagan, J., Collin, N., Timoney, J., Mitchell, T., Mumford, J.A., and Chanter, N. (1998) Characterization of the haemolytic activity of Streptococcus equi. Microb Pathog 24: 211-221.
84. Fraser, J.D., and Proft, T. (2008) The bacterial superantigen and superantigen-like proteins. Immunol Rev 225: 226-243.
85. Fuller, J.D., Camus, A.C., Duncan, C.L., Nizet, V., Bast, D.J., Thune, R.L., et al. (2002) Identification of a streptolysin S-associated gene cluster and its role in the pathogenesis of Streptococcus iniae disease. Infect Immun 70: 5730-5739.
86. Gase, K., Ferretti, J.J., Primeaux, C., and McShan, W.M. (1999) Identification, cloning, and expression of the CAMP factor gene (cfa) of group A streptococci. Infect Immun 67: 4725-4731.
87. Gilbert, J.V., Plaut, A.G., Fishman, Y., and Wright, A. (1988) Cloning of the gene encoding streptococcal immunoglobulin A protease and its expression in Escherichia coli. Infect Immun 56: 1961-1966.
88. Ginsburg, I. (1999) Is streptolysin S of group A streptococci a virulence factor? APMIS 107: 1051-1059.
89. Gonzalez, M.R., Bischofberger, M., Pernot, L., van der Goot, F.G., and Freche, B. (2008) Bacterial pore-forming toxins: the (w)hole story? Cell Mol Life Sci 65: 493-507.
90. Gonzalez, M.R., Bischofberger, M., Freche, B., Ho, S., Parton, R.G., and van der Goot, F.G. (2011) Pore-forming toxins induce multiple cellular responses promoting survival. Cell Microbiol 13: 1026-1043.
91. Gottschalk, M.G., Lacouture, S., and Dubreuil, J.D. (1995) Characterization of Streptococcus suis capsular type 2 haemolysin. Microbiology 141: 189-195.
92. Govindarajan, B., Menon, B.B., Spurr-Michaud, S., Rastogi, K., Gilmore, M.S., Argueso, P., and Gipson, I.K. (2012) A metalloproteinase secreted by Streptococcus pneumoniae removes membrane mucin MUC16 from the epithelial glycocalyx barrier. PLoS One 7: e32418.
93. Greene, N.G., Narciso, A.R., Filipe, S.R., and Camilli, A. (2015) Peptidoglycan branched stem peptides contribute to Streptococcus pneumoniae virulence by inhibiting pneumolysin release. PLoS Pathog 11: e1004996.
94. Harris, A.L. (1997) Clinical trials of anti-vascular agent group B Streptococcus toxin (CM101). Angiogenesis 1: 36-37.
95. Hartwig, U.F., Gerlach, D., and Fleischer, B. (1994) Major histocompatibility complex class II binding site for streptococcal pyrogenic (erythrogenic) toxin A. Med Microbiol Immun 183: 257-264.
96. Hasan, I., Watanabe, M., Ishizaki, N., Sugita-Konishi, Y., Kawakami, Y., Suzuki, J., et al. (2014) A galactose-binding lectin isolated from Aplysia kurodai (sea hare) eggs inhibits streptolysin-induced hemolysis. Molecules 19: 13990-14003.
97. Hashikawa, S., Iinuma, Y., Furushita, M., Ohkura, T., Nada, T., Torii, K., et al. (2004) Characterization of group C and G streptococcal strains that cause streptococcal toxic shock syndrome. J Clin Microbiol 42: 186-192.
98. Hensler, M.E., Liu, G.Y., Sobczak, S., Benirschke, K., Nizet, V., and Heldt, G.P. (2005) Virulence role of group B Streptococcus beta-hemolysin/cytolysin in a neonatal rabbit model of early-onset pulmonary infection. J Infect Dis 191: 1287-1291.
99. Hensler, M.E., Quach, D., Hsieh, C.J., Doran, K.S., and Nizet, V. (2008) CAMP factor is not essential for systemic virulence of group B Streptococcus. Microb Pathog 44: 84-88.
100. Heuck, A.P., Moe, P.C., and Johnson, B.B. (2010) The cholesterol-dependent cytolysin family of Gram-positive bacterial toxins. Subcell Biochem 51: 551-577.
101. Hidalgo-Grass, C., Dan-Goor, M., Maly, A., Eran, Y., Kwinn, L.A., Nizet, V., et al. (2004) Effect of a bacterial pheromone peptide on host chemokine degradation in group A streptococcal necrotising soft-tissue infections. Lancet 363: 696-703.
102. Hidalgo-Grass, C., Mishalian, I., Dan-Goor, M., Belotserkovsky, I., Eran, Y., Nizet, V., et al. (2006) A streptococcal protease that degrades CXC chemokines and impairs bacterial clearance from infected tissues. EMBO J 25: 4628-4637.
103. Hoff, J.S., DeWald, M., Moseley, S.L., Collins, C.M., and Voyich, J.M. (2011) SpyA, a C3-like ADP-ribosyltransferase, contributes to virulence in a mouse subcutaneous model of Streptococcus pyogenes infection. Infect Immun 79: 2404-2411.
104. Hollands, A., Aziz, R.K., Kansal, R., Kotb, M., Nizet, V., and Walker, M.J. (2008) A naturally occurring mutation in ropB suppresses SpeB expression and reduces M1T1 group A streptococcal systemic virulence. PLoS One 3: e4102.
105. Honda-Ogawa, M., Ogawa, T., Terao, Y., Sumitomo, T., Nakata, M., Ikebe, K., et al. (2013) Cysteine proteinase from Streptococcus pyogenes enables evasion of innate immunity via degradation of complement factors. J Biol Chem 288: 15854-15864.
106. Hu, Q., Liu, P., Yu, Z., Zhao, G., Li, J., Teng, L., et al. (2010) Identification of a cell wall-associated subtilisin-like serine protease involved in the pathogenesis of Streptococcus suis serotype 2. Microb Pathog 48: 103-109.
107. Hulting, G., Flock, M., Frykberg, L., Lannergard, J., Flock, J.I., and Guss, B. (2009) Two novel IgG endopeptidases of Streptococcus equi. FEMS Microbiol Lett 298: 44-50.
108. Humar, D., Datta, V., Bast, D.J., Beall, B., De Azavedo, J.C., and Nizet, V. (2002) Streptolysin S and necrotising infections produced by group G Streptococcus. Lancet 359: 124-129.
109. Icenogle, L.M., Hengel, S.M., Coye, L.H., Streifel, A., Collins, C.M., Goodlett, D.R., and Moseley, S.L. (2012) Molecular and biological characterization of streptococcal SpyA-mediated ADP-ribosylation of intermediate filament protein vimentin. J Biol Chem 287: 21481-21491.
110. Igwe, E.I., Shewmaker, P.L., Facklam, R.R., Farley, M.M., van Beneden, C., and Beall, B. (2003) Identification of superantigen genes speM, ssa, and smeZ in invasive strains of beta-hemolytic group C and G streptococci recovered from humans. FEMS Microbiol Lett 229: 259-264.
111. Ikebe, T., Wada, A., Inagaki, Y., Sugama, K., Suzuki, R., Tanaka, D., et al. (2002) Dissemination of the phage-associated novel superantigen gene speL in recent invasive and noninvasive Streptococcus pyogenes M3/T3 isolates in Japan. Infect Immun 70: 3227-3233.
112. Ikebe, T., Ato, M., Matsumura, T., Hasegawa, H., Sata, T., Kobayashi, K., and Watanabe, H. (2010) Highly frequent mutations in negative regulators of multiple virulence genes in group A streptococcal toxic shock syndrome isolates. PLoS Pathog 6: e1000832.
113. Ivaska, J., Pallari, H.M., Nevo, J., and Eriksson, J.E. (2007) Novel functions of vimentin in cell adhesion, migration, and signaling. Exp Cell Res 313: 2050-2062.
114. Jacobs, J.A., Pietersen, H.G., Stobberingh, E.E., and Soeters, P.B. (1995) Streptococcus anginosus, Streptococcus constellatus and Streptococcus intermedius. Clinical relevance, hemolytic and serologic characteristics. Am J Clin Path 104: 547-553.
115. Janoff, E.N., Rubins, J.B., Fasching, C., Charboneau, D., Rahkola, J.T., Plaut, A.G., and Weiser, J.N. (2014) Pneumococcal IgA1 protease subverts specific protection by human IgA1. Mucosal Immunol 7: 249-256.
116. Ji, Y., McLandsborough, L., Kondagunta, A., and Cleary, P.P. (1996) C5a peptidase alters clearance and trafficking of group A streptococci by infected mice. Infect Immun 64: 503-510.
117. Johansson, L., Thulin, P., Sendi, P., Hertzen, E., Linder, A., Akesson, P., et al. (2008) Cathelicidin LL-37 in severe Streptococcus pyogenes soft tissue infections in humans. Infect Immun 76: 3399-3404.
118. Johnson, S., Brooks, N.J., Smith, R.A., Lea, S.M., and Bubeck, D. (2013) Structural basis for recognition of the pore-forming toxin intermedilysin by human complement receptor CD59. Cell Rep 3: 1369-1377.
119. Jupin, C., Anderson, S., Damais, C., Alouf, J.E., and Parant, M. (1988) Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and γ interferon. J Exp Med 167: 752-761.
120. Jurgens, D., Sterzik, B., and Fehrenbach, F.J. (1987) Unspecific binding of group B streptococcal cocytolysin (CAMP factor) to immunoglobulins and its possible role in pathogenicity. J Exp Med 165: 720-732.
121. Kadioglu, A., Gingles, N.A., Grattan, K., Kerr, A., Mitchell, T.J., and Andrew, P.W. (2000) Host cellular immune response to pneumococcal lung infection in mice. Infect Immun 68: 492-501.
122. Kamezawa, Y., Nakahara, T., Nakano, S., Abe, Y., Nozaki-Renard, J., and Isono, T. (1997) Streptococcal mitogenic exotoxin Z, a novel acidic superantigenic toxin produced by a T1 strain of Streptococcus pyogenes. Infect Immun 65: 3828-3833.
123. Kamtchoua, T., Bologa, M., Hopfer, R., Neveu, D., Hu, B., Sheng, X., et al. (2013) Safety and immunogenicity of the pneumococcal pneumolysin derivative PlyD1 in a single-antigen protein vaccine candidate in adults. Vaccine 31: 327-333.
124. Kansal, R.G., McGeer, A., Low, D.E., Norrby-Teglund, A., and Kotb, M. (2000) Inverse relation between disease severity and expression of the streptococcal cysteine protease, SpeB, among clonal M1T1 isolates recovered from invasive group A streptococcal infection cases. Infect Immun 68: 6362-6369.
125. Kapur, V., Maffei, J.T., Greer, R.S., Li, L.L., Adams, G.J., and Musser, J.M. (1994) Vaccination with streptococcal extracellular cysteine protease (interleukin-1 beta convertase) protects mice against challenge with heterologous group A streptococci. Microb Pathog 16: 443-450.
126. Karasawa, T., Takasawa, S., Yamakawa, K., Yonekura, H., Okamoto, H., and Nakamura, S. (1995) NAD(+)-glycohydrolase from Streptococcus pyogenes shows cyclic ADP-ribose forming activity. FEMS Microbiol Lett 130: 201-204.
127. Kasper, K.J., Zeppa, J.J., Wakabayashi, A.T., Xu, S.X., Mazzuca, D.M., Welch, I., et al. (2014) Bacterial superantigens promote acute nasopharyngeal infection by Streptococcus pyogenes in a human MHC class II-dependent manner. PLoS Pathog 10: e1004155.
128. Kaur, S.J., Nerlich, A., Bergmann, S., Rohde, M., Fulde, M., Zahner, D., et al. (2010) The CXC chemokine-degrading protease SpyCEP of Streptococcus pyogenes promotes its uptake into endothelial cells. J Biol Chem 285: 27798-27805.
129. Kirkham, L.A., Kerr, A.R., Douce, G.R., Paterson, G.K., Dilts, D.A., Liu, D.F., and Mitchell, T.J. (2006) Construction and immunological characterization of a novel nontoxic protective pneumolysin mutant for use in future pneumococcal vaccines. Infect Immun 74: 586-593.
130. Koh, T.H., Sng, L.H., Yuen, S.M., Thomas, C.K., Tan, P.L., Tan, S.H., and Wong, N.S. (2009) Streptococcal cellulitis following preparation of fresh raw seafood. Zoonoses Public Health 56: 206-208.
131. Koppe, U., Hogner, K., Doehn, J.M., Muller, H.C., Witzenrath, M., Gutbier, B., et al. (2012) Streptococcus pneumoniae stimulates a STING- and IFN regulatory factor 3-dependent type I IFN production in macrophages, which regulates RANTES production in macrophages, cocultured alveolar epithelial cells, and mouse lungs. J Immunol 188: 811-817.
132. Korotkova, N., Hoff, J.S., Becker, D.M., Quinn, J.K., Icenogle, L.M., and Moseley, S.L. (2012) SpyA is a membrane-bound ADP-ribosyltransferase of Streptococcus pyogenes which modifies a streptococcal peptide, SpyB. Mol Microbiol 83: 936-952.
133. Lalonde, M., Segura, M., Lacouture, S., and Gottschalk, M. (2000) Interactions between Streptococcus suis serotype 2 and different epithelial cell lines. Microbiology 146: 1913-1921.
134. Lang, S., and Palmer, M. (2003) Characterization of Streptococcus agalactiae CAMP factor as a pore-forming toxin. J Biol Chem 278: 38167-38173.
135. Lang, S., Xue, J., Guo, Z., and Palmer, M. (2007) Streptococcus agalactiae CAMP factor binds to GPI-anchored proteins. Med Microbiol Immun 196: 1-10.
136. Lannergard, J., and Guss, B. (2006) IdeE, an IgG-endopeptidase of Streptococcus equi ssp. equi. FEMS Microbiol Lett 262: 230-235.
137. Lappin, E., and Ferguson, A.J. (2009) Gram-positive toxic shock syndromes. Lancet Infect Dis 9: 281-290.
138. Lei, B., DeLeo, F.R., Hoe, N.P., Graham, M.R., Mackie, S.M., Cole, R.L., et al. (2001) Evasion of human innate and acquired immunity by a bacterial homolog of CD11b that inhibits opsonophagocytosis. Nat Med 7: 1298-1305.
139. Leung, D.Y.M., Walsh, P., Giorno, R., and Norris, D.A. (1993) A potential role for superantigens in the pathogenesis of psoriasis. J Invest Dermatol 100: 225-228.
140. Lewis, H.M., Baker, B.S., Bokth, S., Powles, A.V., Garioch, J.J., Valdimarsson, H., and Fry, L. (1993) Restricted T-cell receptor Vβ gene usage in the skin of patients with guttate and chronic plaque psoriasis. Br J Dermatol 129: 514-520.
141. Li, P.L., Tiedemann, R.E., Moffat, S.L., and Fraser, J.D. (1997) The superantigen streptococcal pyrogenic exotoxin C (SPE-C) exhibits a novel mode of action. J Exp Med 186: 375-383.
142. Limbago, B., Penumalli, V., Weinrick, B., and Scott, J.R. (2000) Role of streptolysin O in a mouse model of invasive group A streptococcal disease. Infect Immun 68: 6384-6390.
143. Lin, A., Loughman, J.A., Zinselmeyer, B.H., Miller, M.J., and Caparon, M.G. (2009) Streptolysin S inhibits neutrophil recruitment during the early stages of Streptococcus pyogenes infection. Infect Immun 77: 5190-5201.
144. Lin, A.E., Beasley, F.C., Keller, N., Hollands, A., Urbano, R., Troemel, E.R., et al. (2015) A group A Streptococcus ADP-ribosyltransferase toxin stimulates a protective interleukin 1beta-dependent macrophage immune response. mBio 6: e00133.
145. Liu, G.Y., Doran, K.S., Lawrence, T., Turkson, N., Puliti, M., Tissi, L., and Nizet, V. (2004) Sword and shield: linked group B streptococcal beta-hemolysin/cytolysin and carotenoid pigment function to subvert host phagocyte defense. Proc Natl Acad Sci U S A 101: 14491-14496.
146. Locke, J.B., Colvin, K.M., Varki, N., Vicknair, M.R., Nizet, V., and Buchanan, J.T. (2007) Streptococcus iniae beta-hemolysin streptolysin S is a virulence factor in fish infection. Dis Aquat Organ 76: 17-26.
147. Logsdon, L.K., Hakansson, A.P., Cortes, G., and Wessels, M.R. (2011) Streptolysin O inhibits clathrin-dependent internalization of group A Streptococcus. mBio 2: e00332-00310.
148. Love, J.F., Tran-Winkler, H.J., and Wessels, M.R. (2012) Vitamin D and the human antimicrobial peptide LL-37 enhance group A Streptococcus resistance to killing by human cells. mBio 3: e00394-12.
149. Lucas, R., Czikora, I., Sridhar, S., Zemskov, E., Gorshkov, B., Siddaramappa, U., et al. (2013) Mini-review: novel therapeutic strategies to blunt actions of pneumolysin in the lungs. Toxins 5: 1244-1260.
150. Lukomski, S., Sreevatsan, S., Amberg, C., Reichardt, W., Woischnik, M., Podbielski, A., and Musser, J.M. (1997) Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains. J Clin Invest 99: 2574-2580.
151. Lukomski, S., Montgomery, C.A., Rurangirwa, J., Geske, R.S., Barrish, J.P., Adams, G.J., and Musser, J.M. (1999) Extracellular cysteine protease produced by Streptococcus pyogenes participates in the pathogenesis of invasive skin infection and dissemination in mice. Infect Immun 67: 1779-1788.
152. Lun, S., Perez-Casal, J., Connor, W., and Willson, P.J. (2003) Role of suilysin in pathogenesis of Streptococcus suis capsular serotype 2. Microb Pathog 34: 27-37.
153. Madden, J.C., Ruiz, N., and Caparon, M. (2001) Cytolysin-mediated translocation (CMT): a functional equivalent of type III secretion in Gram-positive bacteria. Cell 104: 143-152.
154. Malley, R., Henneke, P., Morse, S.C., Cieslewicz, M.J., Lipsitch, M., Thompson, C.M., et al. (2003) Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc Natl Acad Sci U S A 100: 1966-1971.
155. McCormick, J.K., Pragman, A.A., Stolpa, J.C., Leung, D.Y., and Schlievert, P.M. (2001) Functional characterization of streptococcal pyrogenic exotoxin J, a novel superantigen. Infect Immun 69: 1381-1388.
156. McNeela, E.A., Burke, A., Neill, D.R., Baxter, C., Fernandes, V.E., Ferreira, D., et al. (2010) Pneumolysin activates the NLRP3 inflammasome and promotes proinflammatory cytokines independently of TLR4. PLoS Pathog 6: e1001191.
157. Melby, J.O., Nard, N.J., and Mitchell, D.A. (2011) Thiazole/oxazole-modified microcins: complex natural products from ribosomal templates. Curr Opin Chem Biol 15: 369-378.
158. Menon, B.B., and Govindarajan, B. (2013) Identification of an atypical zinc metalloproteinase, ZmpC, from an epidemic conjunctivitis-causing strain of Streptococcus pneumoniae. Microb Pathog 56: 40-46.
159. Michos, A., Gryllos, I., Hakansson, A., Srivastava, A., Kokkotou, E., and Wessels, M.R. (2006) Enhancement of streptolysin O activity and intrinsic cytotoxic effects of the group A streptococcal toxin, NAD-glycohydrolase. J Biol Chem 281: 8216-8223.
160. Mitchell, T.J., and Dalziel, C.E. (2014) The biology of pneumolysin. Subcell Biochem 80: 145-160.
161. Mitchell, T.J., Andrew, P.W., Saunders, F.K., Smith, A.N., and Boulnois, G.J. (1991) Complement activation and antibody binding by pneumolysin via a region of the toxin homologous to a human acute-phase protein. Mol Microbiol 5: 1883-1888.
162. Mitchell, D.A., Lee, S.W., Pence, M.A., Markley, A.L., Limm, J.D., Nizet, V., and Dixon, J.E. (2009) Structural and functional dissection of the heterocyclic peptide cytotoxin streptolysin S. J Biol Chem 284: 13004-13012.
163. Miyoshi-Akiyama, T., Zhao, J., Kato, H., Kikuchi, K., Totsuka, K., Kataoka, Y., et al. (2003) Streptococcus dysgalactiae-derived mitogen (SDM), a novel bacterial superantigen: characterization of its biological activity and predicted tertiary structure. Mol Microbiol 47: 1589-1599.
164. Miyoshi-Akiyama, T., Takamatsu, D., Koyanagi, M., Zhao, J., Imanishi, K., and Uchiyama, T. (2005) Cytocidal effect of Streptococcus pyogenes on mouse neutrophils in vivo and the critical role of streptolysin S. J Infect Dis 192: 107-116.
165. Mollick, J.A., Miller, G.G., Musser, J.M., Cook, R.G., Grossman, D., and Rich, R.R. (1993) A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C. J Clin Invest 92: 710-719.
166. Molloy, E.M., Cotter, P.D., Hill, C., Mitchell, D.A., and Ross, R.P. (2011) Streptolysin S-like virulence factors: the continuing sagA. Nature Rev Microbiol 9: 670-681.
167. Mozola, C.C., Magassa, N., and Caparon, M.G. (2014) A novel cholesterol-insensitive mode of membrane binding promotes cytolysin-mediated translocation by streptolysin O. Mol Microbiol 94: 675-687.
168. Müller-Alouf, H., Alouf, J.E., Gerlach, D., Ozegowski, J.H., Fitting, C., and Cavaillon, J.M. (1996) Human pro- and anti-inflammatory cytokine patterns induced by Streptococcus pyogenes erythrogenic (pyrogenic) exotoxin A and C superantigens. Infect Immun 64: 1450-1453.
169. Musser, J.M., Hauser, A.R., Kim, M.H., Schlievert, P.M., Nelson, K., and Selander, R.K. (1991) Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proc Natl Acad Sci U S A 88: 2668-2672.
170. Nagamune, H., Ohnishi, C., Katsuura, A., Fushitani, K., Whiley, R.A., Tsuji, A., and Matsuda, Y. (1996) Intermedilysin, a novel cytotoxin specific for human cells secreted by Streptococcus intermedius UNS46 isolated from a human liver abscess. Infect Immun 64: 3093-3100.
171. Nagamune, H., Whiley, R.A., Goto, T., Inai, Y., Maeda, T., Hardie, J.M., and Kourai, H. (2000) Distribution of the intermedilysin gene among the anginosus group streptococci and correlation between intermedilysin production and deep-seated infection with Streptococcus intermedius. J Clin Microbiol 38: 220-226.
172. Nelson, D.C., Garbe, J., and Collin, M. (2011) Cysteine proteinase SpeB from Streptococcus pyogenes - a potent modifier of immunologically important host and bacterial proteins. Biol Chem 392: 1077-1088.
173. Nizet, V. (2002) Streptococcal beta-hemolysins: genetics and role in disease pathogenesis. Trends Microbiol 10: 575-580.
174. Nizet, V., Gibson, R.L., Chi, E.Y., Framson, P.E., Hulse, M., and Rubens, C.E. (1996) Group B streptococcal beta-hemolysin expression is associated with injury of lung epithelial cells. Infect Immun 64: 3818-3826.
175. Nizet, V., Beall, B., Bast, D.J., Datta, V., Kilburn, L., Low, D.E., and De Azavedo, J.C. (2000) Genetic locus for streptolysin S production by group A Streptococcus. Infect Immun 68: 4245-4254.
176. Ofek, I., Bergner-Rabinowitz, S., and Ginsburg, I. (1970) Oxygen-stable hemolysins of group A streptococci. VII. The relation of the leukotoxic factor to streptolysin S. J Infect Dis 122: 517-522.
177. Oggioni, M.R., Memmi, G., Maggi, T., Chiavolini, D., Iannelli, F., and Pozzi, G. (2003) Pneumococcal zinc metalloproteinase ZmpC cleaves human matrix metalloproteinase 9 and is a virulence factor in experimental pneumonia. Mol Microbiol 49: 795-805.
178. Okumura, K., Shimomura, Y., Murayama, S.Y., Yagi, J., Ubukata, K., Kirikae, T., and Miyoshi-Akiyama, T. (2012) Evolutionary paths of streptococcal and staphylococcal superantigens. BMC Genomics 13: 404.
179. Okumura, C.Y., Anderson, E.L., Dohrmann, S., Tran, D.N., Olson, J., von Pawel-Rammingen, U., and Nizet, V. (2013) IgG protease Mac/IdeS is not essential for phagocyte resistance or mouse virulence of M1T1 group A Streptococcus. mBio 4: e00499-00413.
180. Olsen, R.J., Sitkiewicz, I., Ayeras, A.A., Gonulal, V.E., Cantu, C., Beres, S.B., et al. (2010) Decreased necrotizing fasciitis capacity caused by a single nucleotide mutation that alters a multiple gene virulence axis. Proc Natl Acad Sci U S A 107: 888-893.
181. O'Seaghdha, M., and Wessels, M.R. (2013) Streptolysin O and its co-toxin NAD-glycohydrolase protect group A Streptococcus from xenophagic killing. PLoS Pathog 9: e1003394.
182. Paillot, R., Darby, A.C., Robinson, C., Wright, N.L., Steward, K.F., Anderson, E., et al. (2010) Identification of three novel superantigen-encoding genes in Streptococcus equi subsp. zooepidemicus, szeF, szeN, and szeP. Infect Immun 78: 4817-4827.
183. Palmer, M. (2001) The family of thiol-activated, cholesterol-binding cytolysins. Toxicon 39: 1681-1689.
184. Papageorgiou, A.C., and Acharya, K.R. (1997) Superantigens as immunomodulators: recent structural insights. Structure 5: 991-996.
185. Park, H.S., and Cleary, P.P. (2005) Active and passive intranasal immunizations with streptococcal surface protein C5a peptidase prevent infection of murine nasal mucosa-associated lymphoid tissue, a functional homologue of human tonsils. Infect Immun 73: 7878-7886.
186. Paton, J.C., Rowan-Kelly, B., and Ferrante, A. (1984) Activation of human complement by the pneumococcal toxin pneumolysin. Infect Immun 43: 1085-1087.
187. Paton, J.C., Lock, R.A., Lee, C-J., Li, J.P., Berry, A.M., Mitchell, T.J., et al. (1991) Purification and immunogenicity of genetically obtained pneumolysin toxoids and their conjugation to Streptococcus pneumoniae type 19F polysaccharide. Infect Immun 59: 2297-2304.
188. von Pawel-Rammingen, U. (2012) Streptococcal IdeS and its impact on immune response and inflammation. J Innate Immun 4: 132-140.
189. von Pawel-Rammingen, U., Johansson, B.P., and Bjorck, L. (2002) IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G. EMBO J 21: 1607-1615.
190. Persson, H., Vindebro, R., and von Pawel-Rammingen, U. (2013) The streptococcal cysteine protease SpeB is not a natural immunoglobulin-cleaving enzyme. Infect Immun 81: 2236-2241.
191. Pillich, H., Loose, M., Zimmer, K.P., and Chakraborty, T. (2012) Activation of the unfolded protein response by Listeria monocytogenes. Cell Microbiol 14: 949-964.
192. Podbielski, A., Blankenstein, O., and Lutticken, R. (1994) Molecular characterization of the cfb gene encoding group B streptococcal CAMP-factor. Med Microbiol Immun 183: 239-256.
193. Price, K.E., Greene, N.G., and Camilli, A. (2012) Export requirements of pneumolysin in Streptococcus pneumoniae. J Bacteriol 194: 3651-3660.
194. Pritzlaff, C.A., Chang, J.C., Kuo, S.P., Tamura, G.S., Rubens, C.E., and Nizet, V. (2001) Genetic basis for the beta-haemolytic/cytolytic activity of group B Streptococcus. Mol Microbiol 39: 236-247.
195. Proft, T., and Fraser, J.D. (2007) Streptococcal superantigens. Chem Immunol Allergy 93: 1-23.
196. Proft, T., Moffatt, S.L., Berkahn, C.J., and Fraser, J.D. (1999) Identification and characterization of novel superantigens from Streptococcus pyogenes. J Exp Med 189: 89-102.
197. Proft, T., Arcus, V.L., Handley, V., Baker, E.N., and Fraser, J.D. (2001) Immunological and biochemical characterization of streptococcal pyrogenic exotoxins I and J (SPE-I and SPE-J) from Streptococcus pyogenes. J Immunol 166: 6711-6719.
198. Proft, T., Sriskandan, S., Yang, L., and Fraser, J.D. (2003a) Superantigens and streptococcal toxic shock syndrome. Emerg Infect Dis 9: 1211-1218.
199. Proft, T., Webb, P.D., Handley, V., and Fraser, J.D. (2003b) Two novel superantigens found in both group A and group C Streptococcus. Infect Immun 71: 1361-1369.
200. Puliti, M., Nizet, V., von Hunolstein, C., Bistoni, F., Mosci, P., Orefici, G., and Tissi, L. (2000) Severity of group B streptococcal arthritis is correlated with beta-hemolysin expression. J Infect Dis 182: 824-832.
201. Purushothaman, S.S., Park, H.S., and Cleary, P.P. (2004) Promotion of fibronectin independent invasion by C5a peptidase into epithelial cells in group A Streptococcus. Indian J Med Res 119: S44-S47.
202. Randis, T.M., Gelber, S.E., Hooven, T.A., Abellar, R.G., Akabas, L.H., Lewis, E.L., et al. (2014) Group B Streptococcus beta-hemolysin/cytolysin breaches maternal-fetal barriers to cause preterm birth and intrauterine fetal demise in vivo. J Infect Dis 210: 265-273.
203. Ratner, A.J., Hippe, K.R., Aguilar, J.L., Bender, M.H., Nelson, A.L., and Weiser, J.N. (2006) Epithelial cells are sensitive detectors of bacterial pore-forming toxins. J Biol Chem 281: 12994-12998.
204. Reiss, A., Braun, J.S., Jager, K., Freyer, D., Laube, G., Buhrer, C., et al. (2011) Bacterial pore-forming cytolysins induce neuronal damage in a rat model of neonatal meningitis. J Infect Dis 203: 393-400.
205. Richards, V.P., Zadoks, R.N., Pavinski Bitar, P.D., Lefebure, T., Lang, P., Werner, B., et al. (2012) Genome characterization and population genetic structure of the zoonotic pathogen, Streptococcus canis. BMC Microbiol 12: 293.
206. Ring, A., Braun, J.S., Pohl, J., Nizet, V., Stremmel, W., and Shenep, J.L. (2002) Group B streptococcal beta-hemolysin induces mortality and liver injury in experimental sepsis. J Infect Dis 185: 1745-1753.
207. Rossjohn, J., Gilbert, R.J., Crane, D., Morgan, P.J., Mitchell, T.J., Rowe, A.J., et al. (1998) The molecular mechanism of pneumolysin, a virulence factor from Streptococcus pneumoniae. J Mol Biol 284: 449-461.
208. Sachse, S., Seidel, P., Gerlach, D., Gunther, E., Rodel, J., Straube, E., and Schmidt, K.H. (2002) Superantigen-like gene(s) in human pathogenic Streptococcus dysgalactiae, subsp equisimilis: genomic localisation of the gene encoding streptococcal pyrogenic exotoxin G (speG(dys)). FEMS Immunol Med Microbiol 34: 159-167.
209. Santillan, D.A., Andracki, M.E., and Hunter, S.K. (2008) Protective immunization in mice against group B streptococci using encapsulated C5a peptidase. Am J Obstet Gynecol 198: 114.e1-114.e6.
210. Seele, J., Singpiel, A., Spoerry, C., von Pawel-Rammingen, U., Valentin-Weigand, P., and Baums, C.G. (2013) Identification of a novel host-specific IgM protease in Streptococcus suis. J Bacteriol 195: 930-940.
211. Segura, M., and Gottschalk, M. (2002) Streptococcus suis interactions with the murine macrophage cell line J774: adhesion and cytotoxicity. Infect Immun 70: 4312-4322.
212. Segura, M., Vanier, G., Al-Numani, D., Lacouture, S., Olivier, M., and Gottschalk, M. (2006) Proinflammatory cytokine and chemokine modulation by Streptococcus suis in a whole-blood culture system. FEMS Immunol Med Microbiol 47: 92-106.
213. Seitz, M., Baums, C.G., Neis, C., Benga, L., Fulde, M., Rohde, M., et al. (2013) Subcytolytic effects of suilysin on interaction of Streptococcus suis with epithelial cells. Vet Microbiol 167: 584-591.
214. Senior, B.W., and Woof, J.M. (2005a) Effect of mutations in the human immunoglobulin A1 (IgA1) hinge on its susceptibility to cleavage by diverse bacterial IgA1 proteases. Infect Immun 73: 1515-1522.
215. Senior, B.W., and Woof, J.M. (2005b) The influences of hinge length and composition on the susceptibility of human IgA to cleavage by diverse bacterial IgA1 proteases. J Immunol 174: 7792-7799.
216. Shak, J.R., Ludewick, H.P., Howery, K.E., Sakai, F., Yi, H., Harvey, R.M., et al. (2013) Novel role for the Streptococcus pneumoniae toxin pneumolysin in the assembly of biofilms. mBio 4: e00655-00613.
217. Shewell, L.K., Harvey, R.M., Higgins, M.A., Day, C.J., Hartley-Tassell, L.E., Chen, A.Y., et al. (2014) The cholesterol-dependent cytolysins pneumolysin and streptolysin O require binding to red blood cell glycans for hemolytic activity. Proc Natl Acad Sci U S A 111: E5312-E5320.
218. Shulman, S.T., and Rowley, A.H. (2015) Kawasaki disease: insights into pathogenesis and approaches to treatment. Nature Rev Rheumatol 11: 475-482.
219. Sierig, G., Cywes, C., Wessels, M.R., and Ashbaugh, C.D. (2003) Cytotoxic effects of streptolysin O and streptolysin S enhance the virulence of poorly encapsulated group A streptococci. Infect Immun 71: 446-455.
220. Silva-Costa, C., Carriço, J.A., Ramirez, M., and Melo-Cristino, J. (2014) Scarlet fever is caused by a limited number of Streptococcus pyogenes lineages and is associated with the exotoxin genes ssa, speA and speC. Pediatr Infect Dis J 33: 306-310.
221. Smoot, L.M., McCormick, J.K., Smoot, J.C., Hoe, N.P., Strickland, I., Cole, R.L., et al. (2002) Characterization of two novel pyrogenic toxin superantigens made by an acute rheumatic fever clone of Streptococcus pyogenes associated with multiple disease outbreaks. Infect Immun 70: 7095-7104.
222. Soderberg, J.J., Engstrom, P., and von Pawel-Rammingen, U. (2008) The intrinsic immunoglobulin g endopeptidase activity of streptococcal Mac-2 proteins implies a unique role for the enzymatically impaired Mac-2 protein of M28 serotype strains. Infect Immun 76: 2183-2188.
223. Spaulding, A.R., Salgado-Pabón, W., Kohler, P.L., Horswill, A.R., Leung, D.Y.M., and Schlievert, P.M. (2013) Staphylococcal and streptococcal superantigen exotoxins. Clin Microbiol Rev 26: 422-447.
224. Spellerberg, B. (2000) Pathogenesis of neonatal Streptococcus agalactiae infections. Microbes Infect 2: 1733-1742.
225. Spellerberg, B., Martin, S., Brandt, C., and Lutticken, R. (2000) The cyl genes of Streptococcus agalactiae are involved in the production of pigment. FEMS Microbiol Lett 188: 125-128.
226. Su, Y.F., Chuang, W.J., Wang, S.M., Chen, W.Y., Chiang-Ni, C., Lin, Y.S., et al. (2011) The deficient cleavage of M protein-bound IgG by IdeS: insight into the escape of Streptococcus pyogenes from antibody-mediated immunity. Mol Immunol 49: 134-142.
227. Sukeno, A., Nagamune, H., Whiley, R.A., Jafar, S.I., Aduse-Opoku, J., Ohkura, K., et al. (2005) Intermedilysin is essential for the invasion of hepatoma HepG2 cells by Streptococcus intermedius. Microbiol Immunol 49: 681-694.
228. Sumby, P., Whitney, A.R., Graviss, E.A., DeLeo, F.R., and Musser, J.M. (2006) Genome-wide analysis of group a streptococci reveals a mutation that modulates global phenotype and disease specificity. PLoS Pathog 2 e5.
229. Sumby, P., Zhang, S., Whitney, A.R., Falugi, F., Grandi, G., Graviss, E.A., et al. (2008) A chemokine-degrading extracellular protease made by group A Streptococcus alters pathogenesis by enhancing evasion of the innate immune response. Infect Immun 76: 978-985.
230. Sumitomo, T., Nakata, M., Higashino, M., Terao, Y., and Kawabata, S. (2013) Group A streptococcal cysteine protease cleaves epithelial junctions and contributes to bacterial translocation. J Biol Chem 288: 13317-13324.
231. Sundell, H.W., Yan, H., Carter, C.E., Wamil, B.D., Wu, K., Gaddipati, R., et al. (2000) Isolation and identification of the group B streptococcal toxin CM101 from infants with sepsis. J Pediatr 137: 338-344.
232. Surewaard, B.G., Trzcinski, K., Jacobino, S.R., Hansen, I.S., Vughs, M.M., Sanders, E.A., et al. (2013) Pneumococcal immune evasion: ZmpC inhibits neutrophil influx. Cell Microbiol 15: 1753-1765.
233. Tabata, A., Nakano, K., Ohkura, K., Tomoyasu, T., Kikuchi, K., Whiley, R.A., and Nagamune, H. (2013) Novel twin streptolysin S-like peptides encoded in the sag operon homologue of beta-hemolytic Streptococcus anginosus. J Bacteriol 195: 1090-1099.
234. Tabata, A., Sato, Y., Maya, K., Nakano, K., Kikuchi, K., Whiley, R.A., et al. (2014) A streptolysin S homologue is essential for beta-haemolytic Streptococcus constellatus subsp. constellatus cytotoxicity. Microbiology 160: 980-991.
235. Tanaka, D., Isobe, J., Watahiki, M., Nagai, Y., Katsukawa, C., Kawahara, R., et al. (2008) Genetic features of clinical isolates of Streptococcus dysgalactiae subsp. equisimilis possessing Lancefield's group A antigen. J Clin Microbiol 46: 1526-1529.
236. Tapsall, J.W. (1987) Relationship between pigment production and haemolysin formation by Lancefield group B streptococci. J Med Microbiol 24: 83-87.
237. Tatsuno, I., Isaka, M., Minami, M., and Hasegawa, T. (2010) NADase as a target molecule of in vivo suppression of the toxicity in the invasive M-1 group A streptococcal isolates. BMC Microbiol 10: 144.
238. Terao, Y., Mori, Y., Yamaguchi, M., Shimizu, Y., Ooe, K., Hamada, S., and Kawabata, S. (2008) Group A streptococcal cysteine protease degrades C3 (C3b) and contributes to evasion of innate immunity. J Biol Chem 283: 6253-6260.
239. Thomssen, H., Hoffmann, B., Schank, M., Elewaut, D., Büschenfelde, K.H.M.Z., and Märker-Hermann, E. (2000) There is no disease-specific role for streptococci-responsive synovial T lymphocytes in the pathogenesis of psoriatic arthritis. Med Microbiol Immun 188: 203-207.
240. Timmer, A.M., Timmer, J.C., Pence, M.A., Hsu, L.C., Ghochani, M., Frey, T.G., et al. (2009) Streptolysin O promotes group A Streptococcus immune evasion by accelerated macrophage apoptosis. J Biol Chem 284: 862-871.
241. Todd, E.W. (1934) A comparative serological study of streptolysins derived from human and from animal infections, with notes on pneumococcal haemolysin, tetanolysin and staphylococcus toxin. J Pathol Bacteriol 39: 299-321.
242. Todd, E.W. (1938) The differentiation of two distinct serological varieties of streptolysin, streptolysin O and streptolysin S. J Pathol Bacteriol 47: 423-445.
243. Travers, J.B., Hamid, Q.A., Norris, D.A., Kuhn, C., Giorno, R.C., Schlievert, P.M., et al. (1999) Epidermal HLA-DR and the enhancement of cutaneous reactivity to superantigenic toxins in psoriasis. J Clin Invest 104: 1181-1189.
244. Turner, C.E., Kurupati, P., Jones, M.D., Edwards, R.J., and Sriskandan, S. (2009a) Emerging role of the interleukin-8 cleaving enzyme SpyCEP in clinical Streptococcus pyogenes infection. J Infect Dis 200: 555-563.
245. Turner, C.E., Kurupati, P., Wiles, S., Edwards, R.J., and Sriskandan, S. (2009b) Impact of immunization against SpyCEP during invasive disease with two streptococcal species: Streptococcus pyogenes and Streptococcus equi. Vaccine 27: 4923-4929.
246. Vincents, B., von Pawel-Rammingen, U., Bjorck, L., and Abrahamson, M. (2004) Enzymatic characterization of the streptococcal endopeptidase, IdeS, reveals that it is a cysteine protease with strict specificity for IgG cleavage due to exosite binding. Biochemistry 43: 15540-15549.
247. Vincents, B., Vindebro, R., Abrahamson, M., and von Pawel-Rammingen, U. (2008) The human protease inhibitor cystatin C is an activating cofactor for the streptococcal cysteine protease IdeS. Chem Biol 15: 960-968.
248. Vlaminckx, B.J., Mascini, E.M., Schellekens, J., Schouls, L.M., Paauw, A., Fluit, A.C., et al. (2003) Site-specific manifestations of invasive group a streptococcal disease: type distribution and corresponding patterns of virulence determinants. J Clin Microbiol 41: 4941-4949.
249. Vojtek, I., Pirzada, Z.A., Henriques-Normark, B., Mastny, M., Janapatla, R.P., and Charpentier, E. (2008) Lysogenic transfer of group A Streptococcus superantigen gene among streptococci. J Infect Dis 197: 225-234.
250. Walker, J.A., Allen, R.L., Falmagne, P., Johnson, M.K., and Boulnois, G.J. (1987) Molecular cloning, characterization, and complete nucleotide sequence of the gene for pneumolysin, the sulfhydryl-activated toxin of Streptococcus pneumoniae. Infect Immun 55: 1184-1189.
251. Walker, M.J., Hollands, A., Sanderson-Smith, M.L., Cole, J.N., Kirk, J.K., Henningham, A., et al. (2007) DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection. Nat Med 13: 981-985.
252. Wamil, B.D., Thurman, G.B., Sundell, H.W., DeVore, R.F., Wakefield, G., Johnson, D.H., et al. (1997) Soluble E-selectin in cancer patients as a marker of the therapeutic efficacy of CM101, a tumor-inhibiting anti-neovascularization agent, evaluated in phase I clinical trail. J Cancer Res Clin Oncol 123: 173-179.
253. Wei, Z., Fu, Q., Chen, Y., Li, M., Cong, P., Mo, D., and Liu, X. (2013) Streptococcus equi ssp. zooepidemicus C5a peptidase, a putative invasin, induces protective immune response in mice. Res Vet Sci 95: 444-450.
254. Weinstein, M.R., Litt, M., Kertesz, D.A., Wyper, P., Rose, D., Coulter, M., et al. (1997) Invasive infections due to a fish pathogen, Streptococcus iniae. S. iniae Study Group. New Engl J Med 337: 589-594.
255. Weiser, J.N., Bae, D., Fasching, C., Scamurra, R.W., Ratner, A.J., and Janoff, E.N. (2003) Antibody-enhanced pneumococcal adherence requires IgA1 protease. Proc Natl Acad Sci U S A 100: 4215-4220.
256. Whidbey, C., Harrell, M.I., Burnside, K., Ngo, L., Becraft, A.K., Iyer, L.M., et al. (2013) A hemolytic pigment of Group B Streptococcus allows bacterial penetration of human placenta. J Exp Med 210: 1265-1281.
257. Whiley, R.A., Beighton, D., Winstanley, T.G., Fraser, H.Y., and Hardie, J.M. (1992) Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus (the Streptococcus milleri group): association with different body sites and clinical infections. J Clin Microbiol 30: 243-244.
258. Yoshino, M., Murayama, S.Y., Sunaoshi, K., Wajima, T., Takahashi, M., Masaki, J., et al. (2010) Nonhemolytic Streptococcus pyogenes isolates that lack large regions of the sag operon mediating streptolysin S production. J Clin Microbiol 48: 635-638.
259. Yoshioka, T., Matsutani, T., Toyosaki-Maeda, T., Suzuki, H., Uemura, S., Suzuki, R., et al. (2003) Relation of streptococcal pyrogenic exotoxin C as a causative superantigen for Kawasaki disease. Pediatr Res 53: 403-410.
260. Yu, C.E., and Ferretti, J.J. (1991) Frequency of the erythrogenic toxin B and C genes (speB and speC) among clinical isolates of group A streptococci. Infect Immun 59: 211-215.
261. Zhang, A., Mu, X., Chen, B., Han, L., Chen, H., and Jin, M. (2011) IgA1 protease contributes to the virulence of Streptococcus suis. Vet Microbiol 148: 436-439.
262. Zingaretti, C., Falugi, F., Nardi-Dei, V., Pietrocola, G., Mariani, M., Liberatori, S., et al. (2010) Streptococcus pyogenes SpyCEP: a chemokine-inactivating protease with unique structural and biochemical features. FASEB J 24: 2839-2848.
263. Zinkernagel, A.S., Timmer, A.M., Pence, M.A., Locke, J.B., Buchanan, J.T., Turner, C.E., et al. (2008) The IL-8 protease SpyCEP/ScpC of group A Streptococcus promotes resistance to neutrophil killing. Cell Host Microbe 4: 170-178.
264. Zysk, G., Schneider-Wald, B.K., Hwang, J.H., Bejo, L., Kim, K.S., Mitchell, T.J., et al. (2001) Pneumolysin is the main inducer of cytotoxicity to brain microvascular endothelial cells caused by Streptococcus pneumoniae. Infect Immun 69: 845-852.